# A Safety and Efficacy Study of Squalamine Lactate for Injection (MSI-1256F) for "Wet" Age-Related Macular Degeneration

> **NCT00139282** · PHASE3 · TERMINATED · sponsor: **Genaera Corporation**

## Conditions studied

- "Wet" Age-Related Macular Degeneration

## Interventions

- **DRUG:** Squalamine Lactate

## Key facts

- **NCT ID:** NCT00139282
- **Lead sponsor:** Genaera Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2007-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00139282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00139282, "A Safety and Efficacy Study of Squalamine Lactate for Injection (MSI-1256F) for "Wet" Age-Related Macular Degeneration". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00139282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*